Weihai Lutan Pharmaceutical

Weihai Lutan Pharmaceutical is a specialized Chinese pharmaceutical company and a major production subsidiary of the Lunan Pharmaceutical Group. Based in Weihai, Shandong, the company is primarily dedicated to the development and large-scale manufacturing of cardiovascular and cerebrovascular medications. Its most recognized product is amlodipine besylate, marketed under the brand name Lutan, which is a leading treatment for hypertension in the Chinese market. The company operates state-of-the-art GMP-certified facilities and leverages the extensive research and distribution infrastructure of its parent group. Weihai Lutan plays a critical role in Lunan's strategy to provide high-quality, affordable generic therapies for chronic disease management.